Insider Stock Trading History of Fourteau Patrick


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Fourteau Patrick since year 2005. The trader's CIK number is 1235637. At the time of this reporting, Fourteau Patrick is the Director of Insys Therapeutics, Inc. . (stock ticker symbol INSY). See this page for all insider trading activities at Insys Therapeutics, Inc. .

Note that in the past FOURTEAU PATRICK also reported insider trading activities as an insider of the following companies:
Stock purchases, sales, and option exercises reported by insider Fourteau Patrick since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2017-08-04 INSY Insys Therapeutics, Inc. Option Ex 10,000 1.62 16,200
2017-05-26 INSY Insys Therapeutics, Inc. Option Ex 10,000 3.63 36,300
2016-08-11 INSY Insys Therapeutics, Inc. Sale 15,000 18.46 276,900
2015-11-12 INSY Insys Therapeutics, Inc. Sale 30,000 26.48 794,400
2015-05-26 INSY Insys Therapeutics, Inc. Sale 4,784 60.00 287,040
2015-05-27 INSY Insys Therapeutics, Inc. Sale 1,311 60.14 78,843
2015-05-19 INSY Insys Therapeutics, Inc. Sale 2,969 60.00 178,140
2015-05-20 INSY Insys Therapeutics, Inc. Sale 6,095 60.00 365,700
2015-03-11 INSY Insys Therapeutics, Inc. Sale 10,000 59.94 599,360
2014-11-19 INSY Insys Therapeutics, Inc. Sale 25,000 39.11 977,675
2014-05-15 INSY Insys Therapeutics, Inc. Buy 7,500 22.73 170,437
2013-08-14 INSY Insys Therapeutics, Inc. Buy 5,000 23.77 118,850
2013-05-14 INSY Insys Therapeutics, Inc. Buy 5,000 10.90 54,500
2013-05-13 INSY Insys Therapeutics, Inc. Buy 2,000 11.10 22,200
2013-05-09 INSY Insys Therapeutics, Inc. Buy 2,800 10.75 30,100
2013-05-08 INSY Insys Therapeutics, Inc. Buy 200 10.40 2,080
2013-05-07 INSY Insys Therapeutics, Inc. Buy 50,000 8.72 436,250
2008-08-15 SCRX First Horizon Pharmaceutical Corp Option Ex 100,000 .00 0
2008-08-15 SCRX First Horizon Pharmaceutical Corp Sale 100,000 21.37 2,137,300
2008-05-15 SCRX First Horizon Pharmaceutical Corp Sale 100,000 21.08 2,107,600
2008-05-15 SCRX First Horizon Pharmaceutical Corp Option Ex 100,000 .00 0
2008-02-15 SCRX First Horizon Pharmaceutical Corp Option Ex 52,500 .00 0
2008-02-15 SCRX First Horizon Pharmaceutical Corp Sale 52,500 22.45 1,178,362
2008-01-23 SCRX First Horizon Pharmaceutical Corp Sale 16,508 22.44 370,373
2008-01-24 SCRX First Horizon Pharmaceutical Corp Sale 7,500 23.86 178,957
2007-12-07 SCRX First Horizon Pharmaceutical Corp Sale 28,750 22.75 654,062
2007-10-31 SCRX First Horizon Pharmaceutical Corp Sale 50,000 25.25 1,262,500
2007-09-10 SCRX First Horizon Pharmaceutical Corp Option Ex 100,000 .00 0
2007-09-10 SCRX First Horizon Pharmaceutical Corp Sale 100,000 24.90 2,490,000
2007-05-16 SCRX First Horizon Pharmaceutical Corp Option Ex 52,500 .00 0
2007-05-16 SCRX First Horizon Pharmaceutical Corp Sale 52,500 24.11 1,265,565
2007-01-24 SCRX First Horizon Pharmaceutical Corp Sale 17,500 23.88 417,830
2006-11-01 SCRX First Horizon Pharmaceutical Corp Sale 50,000 21.70 1,085,100
2006-08-01 SCRX First Horizon Pharmaceutical Corp Sale 10,000 20.01 200,100
2006-08-02 SCRX First Horizon Pharmaceutical Corp Sale 39,924 20.14 804,069
2006-05-16 FHRX First Horizon Pharmaceutical Corp Option Ex 105,000 2.52 264,075
2006-05-16 FHRX First Horizon Pharmaceutical Corp Sale 105,000 23.50 2,467,500

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Fourteau Patrick (Director of Insys Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.